Ventilator-associated pneumonia (VAP) is one of the most significant nosocomial infections in intensive care units (ICU) worldwide. Patients who have this infection due to lengthy hospital stays face excessive hospital expenditures and are forced to spend more time away from their families than is necessary. VAP is a prominent cause of morbidity and mortality in ICUs, prompting plenty of studies. The most crucial target is its prevention. Understanding how to reduce VAP would help patients live longer, have a better quality of life, and reduce hospital liability. Ventilator-associated pneumonia bundle (VAPB) has been shown in numerous studies to be an effective treatment for VAP prevention. Healthcare professionals are responsible for providing evidence-based care to avoid complications and improve patient outcomes. The recent SARS-CoV-2 pandemic made the condition worse. The admitting diagnosis of many patients in ICU is pneumonia. In the current situation, each health care worker is more responsible for avoiding additional healthcare-associated infections to patients.

Date of publication

Fall 12-5-2021

Document Type

MSN Capstone Project



Persistent identifier



MSN Education

Included in

Nursing Commons